Kantos Nexthaler (Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous)

Beclometasone dipropionate is a glucocorticoid that penetrates airway cells and binds to intracellular glucocorticoid receptors. This binding alters gene transcription, suppressing inflammatory cytokines, reducing airway edema, and decreasing mucus production, which together lower airway hyper‑responsiveness.

The dose of Kantos Nexthaler is individualized by the prescribing clinician based on the patient’s age, disease severity, and response to therapy. Patients should follow the specific inhalation instructions provided by their healthcare professional and not adjust the dose without medical advice.

Safety data for Kantos Nexthaler in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any potential risk to the fetus or infant, and the decision must be made by the prescriber in consultation with the patient.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Unlike single‑component inhalers, Kantos Nexthaler delivers both an inhaled corticosteroid and a long‑acting β2‑agonist in one device. This dual action can improve adherence, simplify maintenance regimens, and provide combined anti‑inflammatory and bronchodilator benefits compared with using separate corticosteroid and LABA inhalers.

The inhaler should be stored at ambient temperature below 25 °C, kept in its original packaging, protected from moisture and direct sunlight, and out of reach of children. Do not expose the device to extreme heat or humidity.

The patient removes the cap, exhales fully away from the device, then inhales quickly and deeply through the mouthpiece. After inhalation, the breath is held for several seconds to allow optimal drug deposition. No coordination of actuation and inhalation is required with the Nexthaler.

Serious risks include paradoxical bronchospasm, adrenal suppression with prolonged high‑dose use, severe allergic reactions such as anaphylaxis, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience worsening breathlessness, rash, swelling, or irregular heartbeat.

Kantos Nexthaler is contraindicated in individuals with known hypersensitivity to beclometasone, formoterol, or any excipients. It should also be avoided in patients with untreated severe cardiovascular disorders and in those who have experienced a life‑threatening asthma attack requiring mechanical ventilation.